These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3392246)

  • 1. Pharmacokinetics of diltiazem in patients undergoing continuous ambulatory peritoneal dialysis.
    Grech-Bélanger O; Langlois S; LeBoeuf E
    J Clin Pharmacol; 1988 May; 28(5):477-80. PubMed ID: 3392246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roxithromycin disposition in patients on continuous ambulatory peritoneal dialysis.
    Lam YW; Flaherty JF; Yumena L; Schoenfeld PY; Gambertoglio JG
    J Antimicrob Chemother; 1995 Jul; 36(1):157-63. PubMed ID: 8537262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procainamide pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
    Raehl CL; Moorthy AV; Beirne GJ
    Nephron; 1986; 44(3):191-4. PubMed ID: 2431330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of aztreonam administered i.p. in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Nikolaidis P; Dombros N; Alexiou P; Balaskas E; Tourkantonis A
    Perit Dial Int; 1989; 9(1):57-9. PubMed ID: 2488183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of teicoplanin in patients undergoing continuous ambulatory peritoneal dialysis.
    Stamatiadis D; Papaioannou MG; Giamarellos-Bourboulis EJ; Marinaki S; Giamarellou H; Stathakis CP
    Perit Dial Int; 2003; 23(2):127-31. PubMed ID: 12713078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis.
    Debruyne D; Ryckelynck JP; Moulin M; Hurault de Ligny B; Levaltier B; Bigot MC
    Clin Pharmacokinet; 1990 Jun; 18(6):491-8. PubMed ID: 2354592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of diltiazem and its metabolites after repeated single dosing in healthy volunteers.
    Höglund P; Nilsson LG
    Ther Drug Monit; 1989 Sep; 11(5):551-7. PubMed ID: 2815230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of quinapril and its active metabolite quinaprilat during continuous ambulatory peritoneal dialysis.
    Swartz RD; Starmann B; Horvath AM; Olson SC; Posvar EL
    J Clin Pharmacol; 1990 Dec; 30(12):1136-41. PubMed ID: 2273086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of oral diltiazem and five of its metabolites in patients with chronic renal failure.
    Tawashi M; Marc-Aurèle J; Bichet D; Spénard J; Larivière L; Plante D; Caillé G
    Biopharm Drug Dispos; 1991 Mar; 12(2):95-104. PubMed ID: 2031997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cefotetan in patients with end-stage renal failure on maintenance dialysis.
    Browning MJ; Holt HA; White LO; Chapman ST; Banks RA; Reeves DS; Yates RA
    J Antimicrob Chemother; 1986 Jul; 18(1):103-6. PubMed ID: 3463556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
    Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
    Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis.
    Dahl NV; Foote EF; Searson KM; Fein JL; Kapoian T; Steward CA; Sherman RA
    Ann Pharmacother; 1998 Dec; 32(12):1284-9. PubMed ID: 9876807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Absorption of ceftizoxime from peritoneal dialysate and its pharmacokinetics in chronic kidney failure patients].
    Gao S; Li P; Liu GL; Wang SX; Chui RL; Yang JP
    Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):377-80. PubMed ID: 1456067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of diltiazem and its metabolites after single and multiple dosing in healthy volunteers.
    Höglund P; Nilsson LG
    Ther Drug Monit; 1989 Sep; 11(5):558-66. PubMed ID: 2815231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclovir pharmacokinetics in a patient on continuous ambulatory peritoneal dialysis.
    Shah GM; Winer RL; Krasny HC
    Am J Kidney Dis; 1986 Jun; 7(6):507-10. PubMed ID: 3717158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cefdinir and its transfer to dialysate in patients with chronic renal failure undergoing continuous ambulatory peritoneal dialysis.
    Tomino Y; Fukui M; Hamada C; Inoue S; Osada S
    Arzneimittelforschung; 1998 Aug; 48(8):862-7. PubMed ID: 9748717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of diltiazem and its metabolites after repeated multiple-dose treatments in healthy volunteers.
    Höglund P; Nilsson LG
    Ther Drug Monit; 1989 Sep; 11(5):543-50. PubMed ID: 2815229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose pharmacokinetics of cefpirome in patients receiving hemodialysis and in patients treated by continuous ambulatory peritoneal dialysis.
    Veys N; Lameire N; Malerczyk V; Lehr KH; Rosenkranz B; Ringoir S
    Clin Pharmacol Ther; 1993 Oct; 54(4):395-401. PubMed ID: 8222482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological disposition of intravenously administered 14C-labeled diltiazem in healthy volunteers.
    Höglund P; Nilsson LG
    Ther Drug Monit; 1988; 10(4):401-9. PubMed ID: 3201524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.